(Q37801334)

23 August 2017

title

Prescription of lipophilic statins to Alzheimer's disease patients: some controversies to consider (English)

1 reference

23 August 2017

0 references

Elisa Biondi

1

1 reference

23 August 2017

publication date

19 October 2010

1 reference

23 August 2017

published in

Neurological Sciences

1 reference

23 August 2017

volume

32

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

195-201

1 reference

Effects of statins beyond lipid lowering: potential for clinical benefits.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Differentiation increases the resistance of neuronal cells to amyloid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Clinically relevant differences between the statins: implications for therapeutic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Neuroprotective effects of the Alzheimer's disease-related gene seladin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

CNS synaptogenesis promoted by glia-derived cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Does aggressive statin therapy offer improved cholesterol-independent benefits compared to conventional statin treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Alzheimer disease--no target for statin treatment. A mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Therapeutic potential of statins in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Cholesterol attenuates the membrane perturbing properties of beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Re-infection following successful eradication of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

High total cholesterol levels in late life associated with a reduced risk of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Stimulation of bone formation in vitro and in rodents by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Emerging indications for statins: a pluripotent family of agents with several potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Occludin is overexpressed in Alzheimer's disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Statins and osteoporosis: new role for old drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Are side-chain oxidized oxysterols regulators also in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Simvastatin treatment in the SLO syndrome: a safe approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Executive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

An inducible and reversible mouse genetic rescue system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Do Statins Reduce Blood Pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0440-0

Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells

21 January 2018

1 reference

12 December 2020

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology

1 reference

12 December 2020

Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid.

1 reference

12 December 2020

Better outcome after stroke with higher serum cholesterol levels

1 reference

12 December 2020

A new approach to the treatment of osteoporosis.

1 reference

12 December 2020

Statins for non-alcoholic fatty liver disease: a new indication?

1 reference

12 December 2020

Lipid-Lowering Drugs and Risk of Myopathy: A Population-Based Follow-Up Study

1 reference

12 December 2020

Atorvastatin attenuates transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation

1 reference

12 December 2020

Membrane cholesterol enrichment prevents Aβ-induced oxidative stress in Alzheimer's fibroblasts.

1 reference

12 December 2020

Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease: results from an 18-year population-based cohort.

1 reference

12 December 2020

Statin therapy in the treatment of Alzheimer disease: what is the rationale?

1 reference

12 December 2020

10.1007/S10072-010-0440-0

Identifiers

DOI

1 reference

23 August 2017

1 reference